Povezanost koncentracije TNF-α u serumu i insulinske senzitivnosti kod pacova sa dijabetesom melitusom tip 2

  • Branka Đorđević Katedra Biohemija, Medicinski fakultet, Univerzitet u Nišu

Sažetak


Diabetes and obesity are very common associated metabolic disorders that are linked to chronic inflammation. The development of insulin resistance is driven by multiple factors including an increase in levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α). This study aimed to explore the links between TNF-α-mediated inflammation, insulin sensitivity, and body weight gain in the rat model of type 2 diabetes mellitus (T2DM). The experiment was performed on 10 weeks old Wistar rats randomized into 2 groups. T2DM was induced by intraperitoneal injection of streptozotocin, administered 15 minutes after an intraperitoneal injection of nicotinamide. After 6 weeks, the animals were euthanized. Insulin and TNF-α were determined by using an enzyme-linked immunosorbent assay kit. Insulin sensitivity indexes were calculated. The concentration of TNF-α was significantly higher in animals with T2DM when compared to control (p < 0.001). Quantitative Insulin Sensitivity Check Index (QIUCKI) had significantly lower values in animals with T2DM when compared to control (p < 0.001), whereas values calculated for homeostatic model assessment of insulin resistance (HOMA-IR) were significantly higher (p < 0.001). TNF-α correlated positively with HOMA-IR (r = 0.562, p < 0.01) and negatively with QIUCKI (r =- 0.332, p < 0.05). Additionally, TNF-α correlated positively with a specific rate of body weight gain (r = 0.667, p < 0.01) in the observed period. The results suggest that an increase in circulating TNF-α concentration might be associated with an increase in body weight gain and reduced insulin sensitivity in rats with T2DM.

Reference

Akash MSH, Rehman K, Liaqat A. Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resist-ance and Pathogenesis of Type 2 Diabetes Mellitus. J Cell Biochem 2018;119:105-10. [CrossRef] [PubMed]

Alzamil H. Elevated Serum TNF-α Is Related to Obesity in Type 2 Diabetes Mellitus and Is Associated with Glycemic Control and Insulin Resistance. J Obes 2020;2020:5076858. [CrossRef] [PubMed]

Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Metab 2008;295:E1269-76. [CrossRef] [PubMed]

Das UN. Is there a role for bioactive lipids in the pathobiology of diabetes mellitus? Front Endocrinol (Lausanne) 2017;8:182. [CrossRef] [PubMed]

DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Prim 2015;1:1-22. [CrossRef] [PubMed]

Gonzalez Y, Herrera MT, Soldevila G, Garcia-Garcia L, Fabián G, Pérez-Armendariz EM, et al. High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human mono-cytes. BMC Immunol 2012;13:19. [CrossRef] [PubMed]

Hamada D, Maynard R, Schott E, Drinkwater CJ, Ketz JP, Kates SL, et al. Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated with Obesity and Type 2 Diabetes Mellitus. Arthritis Rheumatol 2016;68:1392-402. [CrossRef] [PubMed]

Hossain M, Faruque MO, Kabir G, Hassan N, Sikdar D, Nahar Q, et al. Association of serum TNF-α and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population. Int J Diabetes Mellit 2010;2:165-8. [CrossRef]

Hotamisligil GS. Inflammation and metabolic dis-orders. Nature 2006;444:860-7. [CrossRef] [PubMed]

Hruby A, Hu FB. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics 2015;33(7):673-89. [CrossRef][PubMed]

Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi J Al. Epidemiology of Type 2 dia-betes - Global burden of disease and forecasted trends. J Epidemiol Glob Health 2020;10:107-11. [CrossRef] [PubMed]

Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM: develop-ment of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47: 224-9. [CrossRef] [PubMed]

Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 2003;27:88-94. [CrossRef] [PubMed]

Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA. Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 2003;27:88-94. [CrossRef] [PubMed]

Olmos G, Lladó J. Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Media-tors Inflamm. 2014;2014:861231. [CrossRef] [PubMed]

Olson AL. Regulation of GLUT4 and Insulin-Dependent Glucose Flux. ISRN Mol Biol 2012;2012:1-12. [CrossRef] [PubMed]

Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hypergly-cemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 2010;224:423-32. [CrossRef] [PubMed]

Rajarajeswari D, Ramalingam K, Naidu JN. Tumor necrosis factor-alpha in the development of insulin resistance in type 2 diabetes mellitus. Int J Pharma Bio Sci 2011;2:B.352-B.357.

Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci 2016;23(1):87. [CrossRef] [PubMed]

Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, et al. Insulin/IGF-1 and TNF-alpha stimulate pho-sphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001;107:181-9. [CrossRef] [PubMed]

Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNFα by human muscle: Relationship to insulin resistance. J Clin Invest 1996; 97:1111-6. [CrossRef] [PubMed]

Swaroop JJ, Rajarajeswari D, Naidu JN. Association of TNF-α with insulin resistance in type 2 diabetes melli-tus. Indian J Med Res 2012;135:127-30. [CrossRef] [PubMed]

Szkudelski T. Streptozotocin-nicotinamide-induced dia-betes in the rat. Characteristics of the experi-mental model. Exp Biol Med 2012;237:481-90. [CrossRef] [PubMed]

Objavljeno
2021/10/18
Rubrika
Originalni rad